You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Med., 23 June 2022

Sec. Ophthalmology

Volume 9 - 2022 | https://doi.org/10.3389/fmed.2022.899310

Corrigendum: Efficacy of Initial vs. Delayed Photodynamic Therapy in Combination With Conbercept for Polypoidal Choroidal Vasculopathy

  • 1. School of Ophthalmology & Optometry and Eye Hospital, Wenzhou Medical University, Wenzhou, China

  • 2. Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

  • 3. Department of Ophthalmology, Sir Run Run Shaw Hospital, Medical College of Zhejiang University, Hangzhou, China

  • 4. Bothwin Clinical Study Consultant, Shanghai, China

Article metrics

View details

1,3k

Views

554

Downloads

In the published article, there was an error.

A correction has been made to Abstract, “Conclusions:

This sentence previously stated:

“However, the initial combination group was non-inferior compared with the delayed combination group in terms of the improvement of BCVA.”

The corrected sentence appears below:

“However, the delayed combination group was non-inferior compared with the initial combination group in terms of the improvement of BCVA.”

In the original article, there was an error.

A correction has been made to Conflict of Interest:

This sentence previously stated:

“The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.”

The statement should read:

“JZ was employed by the company Bothwin Clinical Study Consultant Inc.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.”

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

polypoidal choroidal vasculopathy, photodynamic therapy, conbercept, non-inferiority, efficacy

Citation

Sun Z, Gong Y, Yang Y, Huang Y, Yu S, Pei J, Lin B, Zhou R, Li Y, Li Y, Zhang J and Liu X (2022) Corrigendum: Efficacy of Initial vs. Delayed Photodynamic Therapy in Combination With Conbercept for Polypoidal Choroidal Vasculopathy. Front. Med. 9:899310. doi: 10.3389/fmed.2022.899310

Received

18 March 2022

Accepted

24 May 2022

Published

23 June 2022

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

9 - 2022

Updates

Copyright

*Correspondence: Xiaoling Liu

This article was submitted to Ophthalmology, a section of the journal Frontiers in Medicine

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics